A Prospective Randomized Trial Comparing the Efficacy and Adverse Effects of Four Recognized Treatments of Molluscum Contagiosum in Children
- 1 November 2006
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
- Vol. 23 (6), 574-579
- https://doi.org/10.1111/j.1525-1470.2006.00313.x
Abstract
Molluscum contagiosum is a common viral disease of childhood presenting as small, firm, dome-shaped umbilicated papules. Although benign and generally self-limited, this condition is contagious and can lead to complications such as inflammation, pruritus, dermatitis, bacterial superinfection, and scars. No consensus has been established concerning the management of this condition. We conducted a prospective randomized study comparing four common treatments for molluscum contagiosum in 124 children aged 1 to 18 years. One group was treated with curettage, a second with cantharidin, a third with a combination of salicylic acid and lactic acid, and a fourth with imiquimod. Patients needing, respectively, one, two, or three visits for treatment of their mollusca were: 80.6%, 16.1%, and 3.2% for curettage, 36.7%, 43.3%, and 20.0% for cantharidin, 53.6%, 46.4%, and 0% for salicylic acid and glycolic acid, and 55.2%, 41.4%, and 3.4% for imiquimod. The rate of side effects was 4.7% for group 1, 18.6% for group 2, 53.5% for group 3, and 23.3% for group 4. Curettage was found to be the most efficacious treatment and had the lowest rate of side effects. It must be performed with adequate anesthesia and is a time-consuming procedure. Cantharidin is a useful bloodless alternative particularly in the office setting, but has moderate complications due to blisters and necessitated more visits in our experience. The topical keratolytic used was too irritating for children. Topical imiquimod holds promise but the optimum treatment schedule has yet to be determined. Finally, we believe that the ideal treatment for mollusca depends on the individual patient preference, fear, and financial status, distance from the office, and whether they have dermatitis or blood-borne infections.Keywords
This publication has 22 references indexed in Scilit:
- EMLA Cream Provides Rapid Pain Relief for the Curettage of Molluscum Contagiosum in Children with Atopic Dermatitis without Causing Serious Application-Site ReactionsPediatric Dermatology, 2009
- USE OF DUCT TAPE OCCLUSION IN THE TREATMENT OF RECURRENT MOLLUSCUM CONTAGIOSUMPediatric Dermatology, 2004
- Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in childrenBiomedicine & Pharmacotherapy, 2004
- Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: A case series of 16 patientsAustralasian Journal of Dermatology, 2004
- Molluscum contagiosum in Greek children: a case seriesInternational Journal of Dermatology, 2004
- Pediatric Molluscum ContagiosumPediatric Drugs, 2003
- Childhood molluscum contagiosum: Experience with cantharidin therapy in 300 patientsJournal of the American Academy of Dermatology, 2000
- EMLA cream provides rapid pain relief for the curettage of molluscum contagiosum in children with atopic dermatitis without causing serious application-site reactions.Pediatric Dermatology, 1998
- Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum [letter; comment]Pediatric Dermatology, 1998
- Molluscum Contagiosum Treated with Iodine Solution and Salicylic Acid PlasterInternational Journal of Dermatology, 1990